Method for treating autosomal recessive BESTROPHIN disease and evaluation method of autosomal recessive BESTROPHIN disease

Provided herein are methods of treating bestrophin disease, and methods of treating bestrophin disease. The methods comprise administering to an eye of a subject a dose of a recombinant adeno-associated virus (rAAV) vector comprising a nucleic acid sequence encoding a human BEST1 protein, wherein th...

Full description

Saved in:
Bibliographic Details
Main Authors JACOBSON STUART G, AGUIRRE, GEORGE, D, GUZIEWICZ KEITH E, SIDDECIYAN ARTO V, BELTRAN WILLIAM A
Format Patent
LanguageChinese
English
Published 30.12.2022
Subjects
Online AccessGet full text

Cover

More Information
Summary:Provided herein are methods of treating bestrophin disease, and methods of treating bestrophin disease. The methods comprise administering to an eye of a subject a dose of a recombinant adeno-associated virus (rAAV) vector comprising a nucleic acid sequence encoding a human BEST1 protein, wherein the subject has two mutated BEST1 alleles. Methods of assessing treatment of retinal degeneration are also provided. 本文提供了治疗bestrophin病的方法。所述方法包括向受试者的眼睛施用一定剂量的包含编码人BEST1蛋白的核酸序列的重组腺相关病毒(rAAV)载体,其中所述受试者具有两个突变的BEST1等位基因。还提供了评估视网膜变性治疗的方法。
Bibliography:Application Number: CN20218017177